Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.11 - $7.04 $275,370 - $471,680
67,000 Added 55.1%
188,600 $1.07 Million
Q2 2024

Aug 15, 2024

SELL
$3.39 - $5.02 $471,888 - $698,783
-139,200 Reduced 53.37%
121,600 $513,000
Q1 2024

May 07, 2024

SELL
$4.55 - $6.75 $1.76 Million - $2.62 Million
-387,500 Reduced 59.77%
260,800 $1.33 Million
Q4 2023

Feb 14, 2024

BUY
$5.04 - $9.95 $807,912 - $1.59 Million
160,300 Added 32.85%
648,300 $6.04 Million
Q3 2023

Nov 14, 2023

BUY
$6.55 - $9.37 $294,750 - $421,649
45,000 Added 10.16%
488,000 $3.2 Million
Q2 2023

Aug 11, 2023

SELL
$7.66 - $9.5 $430,492 - $533,900
-56,200 Reduced 11.26%
443,000 $3.6 Million
Q1 2023

May 16, 2023

SELL
$8.32 - $11.75 $1.56 Million - $2.2 Million
-187,000 Reduced 27.25%
499,200 $4.28 Million
Q4 2022

Feb 14, 2023

BUY
$7.65 - $14.43 $590,580 - $1.11 Million
77,200 Added 12.68%
686,200 $6.35 Million
Q3 2022

Nov 14, 2022

BUY
$8.9 - $12.86 $767,180 - $1.11 Million
86,200 Added 16.49%
609,000 $6.29 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $847M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.